OYSTER PT PHARMA INC's ticker is OYST and the CUSIP is 69242L106. A total of 60 filers reported holding OYSTER PT PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,202,585 | +100.8% | 107,662 | +0.9% | 0.00% | +100.0% |
Q3 2022 | $599,000 | +29.7% | 106,662 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $462,000 | -62.8% | 106,662 | 0.0% | 0.00% | -50.0% |
Q1 2022 | $1,242,000 | -32.0% | 106,662 | +6.6% | 0.00% | -33.3% |
Q4 2021 | $1,827,000 | +123.1% | 100,029 | +44.8% | 0.00% | +200.0% |
Q3 2021 | $819,000 | -31.0% | 69,073 | 0.0% | 0.00% | -50.0% |
Q2 2021 | $1,187,000 | -6.0% | 69,073 | 0.0% | 0.00% | -33.3% |
Q1 2021 | $1,263,000 | -2.8% | 69,073 | 0.0% | 0.00% | 0.0% |
Q4 2020 | $1,300,000 | – | 69,073 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 2,768,586 | $50,554,000 | 15.36% |
KPCB XIV Associates, LLC | 367,987 | $6,719,000 | 4.17% |
NEA Management Company, LLC | 5,925,287 | $108,196,000 | 2.19% |
Paradigm Biocapital Advisors LP | 304,238 | $5,555,000 | 1.59% |
Sio Capital Management, LLC | 181,857 | $3,321,000 | 1.00% |
COWEN AND COMPANY, LLC | 509,794 | $9,309,000 | 0.84% |
RTW INVESTMENTS, LP | 2,058,504 | $37,588,000 | 0.55% |
ACT CAPITAL MANAGEMENT, LLC | 13,500 | $247,000 | 0.18% |
COOPER CREEK PARTNERS MANAGEMENT LLC | 79,510 | $1,452,000 | 0.17% |
Point72 Asset Management, L.P. | 2,101,441 | $38,372,000 | 0.15% |